The Enzyme Immunoassay (EIA) Reagents and Kits Market Size is valued at 19.80 Billion in 2022 and is predicted to reach 31.60 Billion by the year 2031 at an 5.5 % CAGR during the forecast period for 2023-2031.
Enzyme Immunoassay (EIA) test is one of laboratory technology that is used for measuring the concentration of analytes such as antigen and antibodies in solution. Enzyme Immunoassay (EIA) test includes various types of enzymes such as alkaline phosphatases, glucose oxidase, and carbonic anhydrase the result can be detected by fluorometry or photometry. Enzyme Immunoassay (EIA) is used as a screening test in the treatment of various infectious diseases such as otavirus, syphilis, Rocky Mountain spotted fever, pernicious anemia, and HIV AIDS. Enzyme Immunoassay (EIA) finds application in different healthcare facilities that includes diagnostic laboratories, hospital, and research laboratories. In addition, Enzyme Immunoassay (EIA) is used in academics, and food industry for different applications.
Increasing incidence of diseases such as infectious diseases and cancer is one of the primary driver associated with the growth of global Enzyme Immunoassay (EIA) Reagents and Kits market. Also, continuous development in biomarkers, cost benefit as compared to other diagnostic tests, and increasing adoption of automated platforms for Enzyme Immunoassay (EIA) has led to increasing demand for Enzyme Immunoassay (EIA) test on the market.Based on the product type, market has been segmented into reagents and kits. In terms of technology, enzyme Immunoassays are further classified into competitive ELISA, indirect ELISA, sandwich ELISA, and multiple/portable ELISA. Based on application, Enzyme Immunoassay (EIA) Reagents and Kits market categorised into Infectious diseases, Cardiology, Oncology, Bone and Mineral, Autoimmunity, Endocrinology, Toxicology, Neonatal screening, Hematology, and Others. In term of end-user, the market has been segmented into hospital laboratories, clinical laboratories, pharmaceutical & biotechnology companies, reference laboratories, academics and others.
At regional level, global Enzyme Immunoassay (EIA) Reagents and Kits market has been segmented into North America, Europe, Asia-Pacific, Latin America and Middle East & Africa. In terms of revenue, North America is major contributor for Enzyme Immunoassay (EIA) test products. Higher adoption of new technologically advanced products and rising awareness for early disease diagnosis propels market growth in the region. Increasing awareness of diseases among peoples that leads to regular check-ups for disease management drives the Enzyme Immunoassay (EIA) test market in North America. The market in North Americas is expected to sustain its growth in the forecast period. North America is followed by Europe which is second largest revenue contributor for global Enzyme Immunoassay (EIA) Reagents and Kits market. The market in Europe is growing steadily because of high prevalence and incidence of disease in the region. Also, the presence of well-established diagnostic laboratories that offers fully automated Enzyme Immunoassay (EIA) test systems with increased efficiency of tests. Asia Pacific is third promising revenue contributor which is expected to grow at rapid pace in upcoming year. Countries such as Japan, India and China are major contributors for this market. Emerging and huge population base countries such as China and India offers tremendous market opportunities. Many global manufacturers are trying to capture this market.
| Report Attribute | Specifications |
| Market Size Value In 2022 | USD 19.80 Billion |
| Revenue Forecast In 2031 | USD 31.60 Billion |
| Growth Rate CAGR | CAGR of 5.5 % from 2023 to 2031 |
| Quantitative Units | Representation of revenue in US$ Billion and CAGR from 2023 to 2031 |
| Historic Year | 2019 to 2022 |
| Forecast Year | 2023-2031 |
| Report Coverage | The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
| Segments Covered | By Product Type, By Technology, By Applications |
| Regional Scope | North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
| Country Scope | U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia |
| Competitive Landscape | American Laboratory Products Company, Ltd., Affymetrix, Inc., Thermo Fisher Scientific. Inc., BD Biosciences, bioMérieux SA, Beckman Coulter Inc., Ortho-Clinical Diagnostics, Inc., R&D Systems Inc., QIAGEN, Quidel, Life Technologies Corporation, ZEUS Scientific, Inc, and Others |
| Customization Scope | Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
| Pricing and Available Payment Methods | Explore pricing alternatives that are customized to your particular study requirements. |
Global Enzyme Immunoassay (EIA) Reagents and Kits Market Outlook (Revenue, US$ Mn, 2019 – 2030) By Technology
Global Enzyme Immunoassay (EIA) Reagents and Kits Market Outlook (Revenue, US$ Mn, 2019 – 2030) By Product Type
Global Enzyme Immunoassay (EIA) Reagents and Kits Market Outlook (Revenue, US$ Mn, 2019 – 2030) By Application
Global Enzyme Immunoassay (EIA) Reagents and Kits Market Outlook (Revenue, US$ Mn, 2019 – 2030) By Region
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Enzyme Immunoassay (EIA) Reagents And Kits Market Snapshot
Chapter 4. Global Enzyme Immunoassay (EIA) Reagents And Kits Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: By Product Estimates & Trend Analysis
5.1. By Product & Market Share, 2022 & 2030
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2030 for the following By Product:
5.2.1. Reagents
5.2.2. Kits
Chapter 6. Market Segmentation 2: By Application Estimates & Trend Analysis
6.1. By Application & Market Share, 2022 & 2030
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2030 for the following By Application:
6.2.1. Infectious Diseases
6.2.2. Cardiology
6.2.3. Oncology
6.2.4. Bone and Mineral
6.2.5. Autoimmunity
6.2.6. Endocrinology
6.2.7. Toxicology
6.2.8. Neonatal screening
6.2.9. Hematology
6.2.10. Others
Chapter 7. Market Segmentation 3: By Technology Estimates & Trend Analysis
7.1. By Technology & Market Share, 2022& 2030
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2030 for the following By Technology:
7.2.1. Competitive ELISA
7.2.2. Indirect ELISA
7.2.3. Sandwich ELISA
7.2.4. Multiple/portable ELISA
Chapter 8. Enzyme Immunoassay (EIA) Reagents And Kits Market Segmentation 4: Regional Estimates & Trend Analysis
8.1. North America
8.1.1. North America Enzyme Immunoassay (EIA) Reagents And Kits Market revenue (US$ Million) estimates and forecasts By Product, 2022 - 2030
8.1.2. North America Enzyme Immunoassay (EIA) Reagents And Kits Market revenue (US$ Million) estimates and forecasts By Application, 2022 - 2030
8.1.3. North America Enzyme Immunoassay (EIA) Reagents And Kits Market revenue (US$ Million) estimates and forecasts By Technology, 2022 - 2030
8.1.4. North America Enzyme Immunoassay (EIA) Reagents And Kits Market revenue (US$ Million) estimates and forecasts by country, 2022 - 2030
8.2. Europe
8.2.1. Europe Enzyme Immunoassay (EIA) Reagents And Kits Market revenue (US$ Million) By Product, 2022 - 2030
8.2.2. Europe Enzyme Immunoassay (EIA) Reagents And Kits Market revenue (US$ Million) By Application, 2022 - 2030
8.2.3. Europe Enzyme Immunoassay (EIA) Reagents And Kits Market revenue (US$ Million) estimates and forecasts By Technology, 2022 - 2030
8.2.4. Europe Enzyme Immunoassay (EIA) Reagents And Kits Market revenue (US$ Million) by country, 2022 - 2030
8.3. Asia Pacific
8.3.1. Asia Pacific Enzyme Immunoassay (EIA) Reagents And Kits Market revenue (US$ Million) By Product, 2022 - 2030
8.3.2. Asia Pacific Enzyme Immunoassay (EIA) Reagents And Kits Market revenue (US$ Million) By Application, 2022 - 2030
8.3.3. Asia Pacific Enzyme Immunoassay (EIA) Reagents And Kits Market revenue (US$ Million) estimates and forecasts By Technology, 2022 - 2030
8.3.4. Asia Pacific Enzyme Immunoassay (EIA) Reagents And Kits Market revenue (US$ Million) by country, 2022 - 2030
8.4. Latin America
8.4.1. Latin America Enzyme Immunoassay (EIA) Reagents And Kits Market revenue (US$ Million) By Product, (US$ Million)
8.4.2. Latin America Enzyme Immunoassay (EIA) Reagents And Kits Market revenue (US$ Million) By Application, (US$ Million)
8.4.3. Latin America Enzyme Immunoassay (EIA) Reagents And Kits Market revenue (US$ Million) estimates and forecasts By Technology, 2022 - 2030
8.4.4. Latin America Enzyme Immunoassay (EIA) Reagents And Kits Market revenue (US$ Million) by country, (US$ Million) 2022 - 2030
8.5. Middle East & Africa
8.5.1. Middle East & Africa Enzyme Immunoassay (EIA) Reagents And Kits Market revenue (US$ Million) By Product, (US$ Million)
8.5.2. Middle East & Africa Enzyme Immunoassay (EIA) Reagents And Kits Market revenue (US$ Million) By Application, (US$ Million)
8.5.3. Middle East & Africa Enzyme Immunoassay (EIA) Reagents And Kits Market revenue (US$ Million) estimates and forecasts By Technology, 2022 - 2030
8.5.4. Middle East & Africa Enzyme Immunoassay (EIA) Reagents And Kits Market revenue (US$ Million) by country, (US$ Million) 2022 - 2030
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. American Laboratory Products Company, Ltd.
9.2.2. Affymetrix, Inc.
9.2.3. Thermo Fisher Scientific. Inc.
9.2.4. BD Biosciences
9.2.5. bioMérieux SA
9.2.6. Beckman Coulter Inc.
9.2.7. Ortho-Clinical Diagnostics, Inc.
9.2.8. R&D Systems Inc.
9.2.9. QIAGEN
9.2.10. Quidel
9.2.11. Life Technologies Corporation
9.2.12. ZEUS Scientific, Inc.
9.2.13. Other Key Players